BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11853286)

  • 21. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL; Kindmark A; Brändström H; Abrahamsen B; Petersen S; Stiger F; Stilgren LS; Jensen JE; Vestergaard P; Langdahl BL; Mosekilde L;
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
    Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.
    García-Pérez MA; Moreno-Mercer J; Tarín JJ; Cano A
    Gynecol Endocrinol; 2006 Apr; 22(4):179-84. PubMed ID: 16723303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone changes in postmenopausal Thai women with or without hormonal replacement therapy.
    Limpaphayom K; Taechakraichana N; Poshyachinda M; Jaisamrarn U
    J Med Assoc Thai; 1995 Nov; 78(11):573-7. PubMed ID: 8576666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
    Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
    Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density in rural Thai adults living in Khon Kaen province.
    Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
    J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
    Taechakraichana N; Limpaphayom K; Ninlagarn T; Panyakhamlerd K; Chaikittisilpa S; Dusitsin N
    Obstet Gynecol; 2000 Jan; 95(1):87-94. PubMed ID: 10636509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
    Hypertens Res; 2008 Jun; 31(6):1191-7. PubMed ID: 18716368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
    Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C
    Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up.
    Prelevic GM; Markou A; Arnold A; Bartram C; Puzigaca Z; Ginsburg J
    Maturitas; 2004 Mar; 47(3):229-34. PubMed ID: 15036493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone loss in oophorectomized Thai women.
    Taechakraichana N; Limpaphayom K; Jaisamrarn U; Poshyachinda M
    J Med Assoc Thai; 1997 Jun; 80(6):384-90. PubMed ID: 9240013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
    Kleerekoper M; Brienza RS; Schultz LR; Johnson CC
    Arch Intern Med; 1991 Oct; 151(10):1971-6. PubMed ID: 1929685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in spine and radius bone density during long-term hormone replacement.
    Blake JM; Ryan ED; Beaumont LF; Webber CE
    Can J Physiol Pharmacol; 1999 Jul; 77(7):505-9. PubMed ID: 10535710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Low-dose oral contraception and bone density].
    Karck U; Breckwoldt M
    Ther Umsch; 2001 Sep; 58(9):547-51. PubMed ID: 11594153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.